Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | WANBURY Wanbury Limited Pharma · Small | AHCL Anlon Healthcare Limited Pharma · Small | BAJAJHCARE Bajaj Healthcare Limited Pharma · Small | JAGSNPHARM Jagsonpal Pharmaceuticals Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 64 | 55 | 29 | 57 |
| Verdict | UNDERVALUED | FAIR VALUE | OVERVALUED | FAIR VALUE |
| Style | Growth at Value | FAIR_VALUE | OVERVALUED | Financial Turnaround |
| Piotroski | 7/9 | 6/9 | 7/9 | 8/9 |
| Valuation | 16/30 | 10/30 | 5/30 | 7/30 |
| Growth | 21/25 | 21/25 | 2/25 | 16/25 |
| Quality | 18/20 | 11/20 | 0/20 | 12/20 |
| Balance Sheet | 0/15 | 10/15 | 9/15 | 12/15 |
| Cash Flow | 4/10 | 0/10 | 7/10 | 5/10 |
| Price | ₹265.75 | ₹15.14 | ₹292.1 | ₹201.75 |
| P/E | 13.30 | 28.20 | 21.10 | 29.30 |
| P/B | 6.44 | 3.49 | 1.87 | 4.83 |
| ROE | 68.40% | 18.40% | 9.40% | 17.30% |
| ROCE | 30.80% | 20.80% | 11.50% | 22.70% |
| Debt / Equity | 1.54 | 0.19 | 0.47 | 0.03 |
| FCF Yield | — | — | 1.01% | 0.84% |
| Dividend Y | — | — | 0.34% | 1.26% |
| Altman Z | 3.83 | 5.12 | 3.55 | 8.98 |
| Promoter % | 43.01% | 52.68% | 58.29% | 67.89% |
| Mkt Cap (₹Cr) | 928.00 | 805.00 | 992.00 | 1308.00 |
| Graham # | ₹132.63 | ₹7.25 | ₹128.99 | ₹77.2 |
| Fair PE | 42.0 | 42.0 | 3.8 | 42.0 |
| MoS % | +66.6% | +33.2% | -1555.4% | +25.3% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startWANBURY102
AHCL16
BAJAJHCARE74
JAGSNPHARM34